Angsana Molecular & Diagnostic Laboratory (AMDL) Pte Ltd, a subsidiary of Parkway Pantai group, was established in 2014, and is headquartered in Singapore with branch offices in Hong Kong and Malaysia. AMDL specialises in developing panelised genetic, genomic and molecular based laboratory developed assays in four specialities:
AMDL is a licensed laboratory by the Ministry of Health Singapore and is also accredited by the College of American Pathologists (CAP) since 2015. With this, we can assure our clinicians and patients that our tests are robust and meet the highest standards for clinical quality and safety. AMDL expands the diagnostic menu of Parkway Pantai hospitals and clinics through strategic partnerships with well-established and internationally reputable biotech and diagnostic companies such as Roche Foundation Medicine, Admera Health, Euroimmun, Natera, Thermo Scientific, as well as Singapore start-up companies, such as iGENE, to offer a full complement of 21st century healthcare tools to our valued clinical customers, in Singapore and beyond.
Delivering next generation diagnostics and predictive pathology for precision medicine.
Our mission is a personal one which is to help our patients discover what is the underlying cause of their disease. We aim to do this by applying next generation molecular diagnostics, using the latest evidence based and validated tests, to guide diagnostic, prognostic and treatment decisions for both doctors and patients.
We believe in our mission that by knowing more of what is causing your disease, we can make medicine personal again.